Anadina Garcia

Anadina Garcia, MBS, LATG, currently serves as the Sr. Manager of Nonclinical Operations for Early Development at Vigil Neuroscience since December 2022. Prior experience includes roles as Sr. Nonclinical Study Manager in Toxicology at Bristol Myers Squibb and Preclinical and Nonclinical Study Manager in Toxicology at Karuna Therapeutics. Anadina's earlier positions at Amicus Therapeutics encompassed responsibilities as Sr. Associate Study Monitor and Scientist/Study Manager in In vivo Pharmacology, along with a foundation in preclinical drug development as an Associate Scientist. Before this, Anadina was part of the in vivo Research Support Team at Sanofi, leading extensive studies across various disease models. Educational qualifications include a Master of Business and Science in Drug Discovery and Development from Rutgers University and a Bachelor of Science in Biology from William Paterson University of New Jersey.